TOOLS & RESOURCES

GLOBAL LEFT ATRIAL APPENDAGE
OCCLUSION SUMMIT

11TH GLOBAL LEFT ATRIAL
APPENDAGE OCCLUSION SUMMIT 2022

Left Atrial Appendage Occlusion therapy has become an established and increasingly popular alternative therapy to reduce the risk of AF-related stroke. Clinical research initiatives continue to show the therapeutic opportunities and benefits of this potentially lifesaving therapy. The objective of this meeting is to share ideas, thoughts and exchange experiences among experienced LAA occlusion devices and experts in the field of stroke prevention. It is designed to go beyond discussing the current available clinical data and aims to address new developments.

SESSION 1: WHAT IS NEW?

INTRODUCTORY REMARKS
TRENDS IN AF MANAGEMENT AND ANTITHROMBOTIC STRATEGIES
J. Camm
LATEST CLINICAL EVIDENCE FOR LAA OCCLUSION
L. Boersma
THE BIG DILEMMA 1 - HOW TO SELECT POST-IMPLANT PHARMACOLOGICAL THERAPIES?
J.E. Nielsen-Kudsk
THE BIG DILEMMA 2 - WHAT IS THE RELEVANCE OF PERI-DEVICE LEAKS?
A. Tzikas
THE BIG DILEMMA 3 - WHAT IS THE RELEVANCE OF DRT?
A. Aminian
CONCOMITANT PROCEDURES
D. Arzamendi
PANEL DISCUSSION

SESSION 2: ANATOMY & IMAGING

NAVIGATING THE LEFT ATRIAL APPENDAGE AND UNDERSTANDING ANATOMICAL LANDMARKS
A. Cook
MAKING IT PRACTICAL: HOW TO VISUALIZE THESE ANATOMICAL LANDMARKS?
J. Saw
PRE-PROCEDURAL PLANNING USING TEE
C. Hammerstingl
PRE-PROCEDURAL PLANNING USING CT
P. Garot
FUTURE PERSPECTIVES & IMAGING TECHNOLOGIES FOR BETTER VISUALIZATION
M. Swaans
PANEL DISCUSSION
LIVE CASE

SESSION 3: TIPS & TRICKS

TIPS AND TRICKS: CASE EXAMPLES: CHICKEN WING AND REVERSE CHICKEN WING ANATOMY
L. Pastormerlo
CASE EXAMPLES: VARIOUS COMPLEX ANATOMIES
R. Ibrahim
NEW DELIVERY SYSTEMS: WHAT IS THE VALUE?
J. Saw
PANEL DISCUSSION
CAN NEPHROLOGISTS BE CONVINCED TO REFER PATIENTS?
I. Eitel
PANEL DISCUSSION (CONTINUED)
FUTURE PERSPECTIVES ON PATIENT SELECTION
T. Lewalter
LIVE CASE

Learn more about Left Atrial Appendage Occlusion.

Visit Product Page

MAT-2214725 v2.0 | Item approved for OUS use only.

Copyright © 2023 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v16.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

+